Frequently Asked Questions
The increasing global burden of genetic disorders, cancer, and chronic diseases is one of the most significant drivers fueling the demand for Next Generation Sequencing (NGS) technologies.
The high cost of Next Generation Sequencing (NGS) platforms and reagents presents a significant challenge for the widespread adoption of NGS technologies, particularly in resource-limited settings and developing regions.
U.S., is expected to dominate in the next generation sequencing (NGS) market due to early adoption of genomic technologies.
North America leads the global Next Generation Sequencing (NGS) market, driven by its robust healthcare infrastructure and significant investments in precision medicine and research.
China is expected to witness the highest CAGR in the next generation sequencing (NGS) market.
